HE

Healthcare North America Growth Stage

4 known investors

solvetx.com ↗

Solve Therapeutics is a clinical-stage oncology biotech developing antibody-drug conjugates (ADCs) and radiopharmaceuticals for solid tumors, built around its CloakLink hydrophilic cleavable linker platform and an integrated diagnostic for patient selection. The company has two lead programs in Phase 1 clinical development.

Investors · 4

DE

Decheng Capital✓ verifiedMenlo Park

MA

Matrix Capital Management✓ verifiedPortsmouth

YO

Yosemite✓ verifiedSan Francisco

B4

B4 Capital$10M – $50M